Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Grey Wolf Therapeutics
Maastricht University Medical Center
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.